Cite

HARVARD Citation

    Yerushalmy-Feler, A. et al. (n.d.). P458 Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn's disease (the SPEED-UP study) - A multi-center study from the paediatric IBD Porto group of ESPGHAN. Journal of Crohn's and colitis. p. i435. [Online]. 
  
Back to record